These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 2013901)

  • 41. Prolonged urticaria with purpura: the spectrum of clinical and histopathologic features in a prospective series of 22 patients exhibiting the clinical features of urticarial vasculitis.
    Lee JS; Loh TH; Seow SC; Tan SH
    J Am Acad Dermatol; 2007 Jun; 56(6):994-1005. PubMed ID: 17504716
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Urticarial vasculitis in northern Spain: clinical study of 21 cases.
    Loricera J; Calvo-Río V; Mata C; Ortiz-Sanjuán F; González-López MA; Alvarez L; González-Vela MC; Armesto S; Fernández-Llaca H; Rueda-Gotor J; González-Gay MA; Blanco R
    Medicine (Baltimore); 2014 Jan; 93(1):53-60. PubMed ID: 24378743
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Immunologic aspects of cutaneous vasculitis.
    Sams WM
    Semin Dermatol; 1988 Jun; 7(2):140-8. PubMed ID: 3153435
    [No Abstract]   [Full Text] [Related]  

  • 44. Response of omalizumab in normocomplementemic urticarial vasculitis.
    Chen YD; Krause K; Tu P; Zhao ZT; Maurer M
    J Allergy Clin Immunol Pract; 2020 Jun; 8(6):2114-2117.e2. PubMed ID: 32145404
    [No Abstract]   [Full Text] [Related]  

  • 45. Sustained dapsone-induced remission of hypocomplementemic urticarial vasculitis--a case report.
    Eiser AR; Singh P; Shanies HM
    Angiology; 1997 Nov; 48(11):1019-22. PubMed ID: 9373057
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Hypocomplementemic urticarial vasculitis syndrome].
    Sessler R; Hasche G; Olbricht CJ
    Dtsch Med Wochenschr; 2000 Aug; 125(34-35):1003-6. PubMed ID: 11004912
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Resolution of urticarial vasculitis after treatment of neurocysticercosis.
    Shaigany S; Dabela E; Teich AF; Husain S; Grossman ME
    J Am Acad Dermatol; 2015 Jan; 72(1):e32-3. PubMed ID: 25497947
    [No Abstract]   [Full Text] [Related]  

  • 48. Zoledronate induced urticarial vasculitis.
    Swarnkar B; Biswal S; Agarwal S; Gupta S
    Dermatol Ther; 2021 Nov; 34(6):e15164. PubMed ID: 34676651
    [No Abstract]   [Full Text] [Related]  

  • 49. Hypocomplementemic urticarial vasculitis in systemic lupus erythematosus.
    Her MY; Song JY; Kim DY
    J Korean Med Sci; 2009 Feb; 24(1):184-6. PubMed ID: 19270838
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Hypocomplementemic urticarial vasculitis arising in a patient with immunoglobulin G4-related disease.
    Takao M; Hamada T; Kaji T; Ikeda-Mizuno K; Takehara-Yasuhara C; Ichimura K; Yanai H; Yshino T; Iwatsuki K
    Int J Dermatol; 2016 Apr; 55(4):430-3. PubMed ID: 26276260
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Pulmonary hemosiderosis with normocomplementemic urticarial vasculitis in a child.
    Yuksel H; Yilmaz O; Savas R; Kirmaz C; Sogut A; Ozalp S
    Monaldi Arch Chest Dis; 2007 Mar; 67(1):63-6. PubMed ID: 17564286
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Idiopathic hypocomplementemic urticarial vasculitis-linked neuropathy.
    Filosto M; Cavallaro T; Pasolini G; Broglio L; Tentorio M; Cotelli M; Ferrari S; Padovani A
    J Neurol Sci; 2009 Sep; 284(1-2):179-81. PubMed ID: 19375087
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Hypocomplementemic urticarial vasculitis syndrome: a rare autoimmune entity.
    Balasubramaniam D; Gottwald L; Dominiak N; Rettig N; Bedford-Lyon N; Ahmed M
    Int J Dermatol; 2020 Dec; 59(12):e480-e481. PubMed ID: 32720358
    [No Abstract]   [Full Text] [Related]  

  • 54. Hypocomplementemic urticarial vasculitis with Jaccoud's arthropathy and valvular heart disease: case report and review of the literature.
    Amano H; Furuhata N; Tamura N; Tokano Y; Takasaki Y
    Lupus; 2008 Sep; 17(9):837-41. PubMed ID: 18755866
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Successful treatment of normocomplementemic urticarial vasculitis with omalizumab: A report of three cases and literature review.
    Rattananukrom T; Svetvilas P; Chanprapaph K
    Asian Pac J Allergy Immunol; 2020 Dec; 38(4):286-289. PubMed ID: 30660172
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Case of cutaneous hemophagocytosis in a patient with idiopathic urticarial vasculitis.
    Kurimoto T; Ogawa K; Miyao M; Ishida E; Nomi K; Mitsui Y; Miyagawa F; Shinkuma S; Asada H
    Int J Dermatol; 2023 Mar; 62(3):e180-e181. PubMed ID: 35933653
    [No Abstract]   [Full Text] [Related]  

  • 57. [Urticarial vasculitis associated with essential thrombocythaemia progressing to myelofibrosis].
    Koudoukpo C; Jachiet M; Zini JM; Andreoli A; Pinquier L; Rybojad M; Bosset D; de Masson A; Bagot M; Lebbé C; Bouaziz JD
    Ann Dermatol Venereol; 2014 Dec; 141(12):773-6. PubMed ID: 25433930
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Chronic urticaria--assessment and treatment.
    Fernando S; Broadfoot A
    Aust Fam Physician; 2010 Mar; 39(3):135-8. PubMed ID: 20369115
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Urticarial vasculitis.
    O'Donnell B; Black AK
    Int Angiol; 1995 Jun; 14(2):166-74. PubMed ID: 8609443
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Urticarial vasculitis and urticarial autoinflammatory syndromes.
    Marzano AV; Tavecchio S; Venturini M; Sala R; Calzavara-Pinton P; Gattorno M
    G Ital Dermatol Venereol; 2015 Feb; 150(1):41-50. PubMed ID: 25586657
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.